Acute kidney injury associated with dengue virus infection: a review

Abstract

Acute kidney injury (AKI) is one of the least studied complications of dengue, but it carries high mortality rates and prolonged hospital stay. Due to the severity of this complication, the risk of developing chronic kidney disease (CKD) and the increasing number of dengue cases reported worldwide, particularly in the tropical and subtropical regions of Africa, Southeast Asia and South America, including Brazil, we embarked on this narrative review, aimed to update the epidemiology of AKI associated with dengue, elucidate the main pathophysiological mechanisms of AKI caused by the dengue virus infection, as well as discuss useful information on the prevention and management of AKI in patients with dengue.

Keywords:
Dengue; Arbovirus infections; Acute kidney injury; Dengue virus

Resumo

A injúria renal aguda (IRA) é uma das complicações da dengue menos estudadas, mas que acarreta altas taxas de mortalidade e prolongamento do tempo de internação. Devido à gravidade dessa complicação, ao risco de desenvolvimento de doença renal crônica (DRC) e ao número crescente de casos de dengue relatados no mundo, particularmente nas regiões tropicais e subtropicais da África, Sudeste Asiático e América do Sul, incluindo o Brasil, foi proposta esta revisão narrativa que objetivou atualizar a epidemiologia da IRA associada à dengue, elucidar os principais mecanismos fisiopatológicos da IRA causada pela infecção do vírus da dengue, assim como discutir informações úteis sobre a prevenção e o manejo da IRA em pacientes com dengue.

Descritores:
Dengue; Infecções Por Arbovírus; Injúria Renal Aguda; Vírus Da Dengue

Introduction

Dengue is the most widespread and rapidly growing vector-borne disease¹. An estimated 2.5 billion people in 129 countries live in endemic tropical and subtropical regions and are at risk of contracting dengue, with 105 million people infected each year¹-⁴.

In Brazil, the largest country in Latin America, dengue is an endemic infectious disease, with high morbidity and mortality rates, bringing a severe burden to healthcare services. In 2018, Brazil registered 265,934 cases of dengue, against 1,544,987 cases in 2019. In 2020, there were more 987,173 cases registered, with 554 confirmed deaths⁵-⁷.

Dengue is a viral infection transmitted by arthropods, whose vector is the female mosquito of the genus Aedes, mainly Aedes aegypt⁸. This infection is caused by an RNA virus of the Flaviviridae family, which has different serotypes: DENV-1, DENV-2, DENV-3 and DENV-4⁹-¹¹. Recently, the existence of a fifth serotype (DENV-5) of isolates in Malaysia was postulated during an outbreak in 2007¹²,¹³. However, the scientific community is still waiting for the documentation of new isolates of this serotype⁵ to confirm whether or not it is a new dengue serotype or another unidentified arbovirus¹⁴.

This illness can range from subclinical illness to flu-like symptoms and, although less common, some patients develop the severe form of the disease, with severe bleeding, organ involvement and/or plasma leakage with reduced blood volume. It can be classified as: dengue without warning signs, dengue with warning signs and severe dengue¹⁵,¹⁶. One of the complications of dengue, associated with high morbidity and mortality rates, is acute kidney injury (AKI)¹⁷.

The pathophysiological mechanisms of kidney injury caused by the dengue virus are still not fully understood, with gaps in understanding and, consequently, in the prevention and adequate management of this serious complication in patients with dengue. Thus, the objective of this narrative review is to update the epidemiology of AKI associated with dengue, as well as to review the possible pathophysiological mechanisms of this lesion and to discuss the recommendations for the management and prevention of AKI in patients with dengue.

Epidemiology of kidney injury in dengue

AKI, an abrupt decrease in the glomerular filtration rate, is one of the serious complications found in dengue. In recent decades, the incidence of AKI associated with dengue virus infection has increased significantly¹⁰.

Severe dengue affects about 6.0 to 6.7% of patients diagnosed with dengue¹⁷,¹⁸. Among hospitalized patients with severe dengue 3.3% to 4.8% develop AKI, of which 14.1% require dialysis¹⁷,¹⁹-²⁴. The need for dialysis can reach 70% in patients with dengue in intensive care units (ICU)²³. AKI is associated with increased length of hospital stay and fatal cases of dengue¹⁷,¹⁹. Figure 1 shows the estimated incidence of AKI in patients with dengue.

Figure 1
Estimate of AKI incidence in patients with dengue. PD: peritoneal dialysis; HD: hemodialysis; AKI: Acute Kidney Injury.

Independent risk factors for the development of AKI in patients with dengue are advanced age, male gender, obesity, hemorrhagic fever, rhabdomyolysis, multiple organ dysfunction, diabetes mellitus, concomitant bacterial infection, delay in hospital consultation and use of nephrotoxic drugs¹⁷,²³,²⁵,²⁶.

Thomas et al. studied the impact on the renal function of patients hospitalized with dengue²⁷. The study showed that 73% of patients with non-dialysis chronic kidney disease (CKD) required hemodialysis, against 8% in the kidney transplant group and none in the control group, formed by patients with normal kidney function. After 2 weeks, 32% of patients in the CKD group were still dependent on hemodialysis against none in the other two groups, showing the role of dengue in renal impairment and the high percentage of acute-on-chronic kidney disease, signaling the possibility of definitive renal worsening in some of the affected patients.

Pathophysiology of ira associated with dengue

The pathophysiological mechanisms of kidney injury by the dengue virus are still not completely clear, but several hypotheses can be considered, including shock mechanisms resulting from hypotension, direct injury caused by the virus, indirect mechanism via the immune system and rhabdomyolysis. The combination of two or more of these mechanisms has yet to be considered. Figure 2 shows the associated risk factors and possible mechanisms involved in the development of dengue-induced AKI.

Figure 2
Risk factors and pathophysiological mechanisms involved in the development of dengue-induced AKI.

Kidney injury in dengue is likely due to the hemodynamic fluctuation that can occur throughout the clinical course of the disease. A number of cytokines are associated with dengue severity, including TNFα, interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-12 (IL-12), interleukin-17 (IL-17), macrophage migration inhibition factor, high mobility group box 1 (HMGB1), monocyte chemo-attractant protein-1 (MCP-1) and matrix metalloproteinases¹⁰,²⁸-³¹. This cytokine storm, in addition to activating the complement system and endothelial damage, results in increased vascular permeability with consequent hemoconcentration²⁸,³². This process can result in shock, leading to reduced renal perfusion and kidney injury²⁸,³³. Shock or hypotension is present in 16% to 100% of patients who develop dengue-induced AKI³⁴,³⁵. Endothelial damage directly caused by the virus can also change vascular permeability, aggravating the hemodynamic instability³⁶.

Although these mechanisms that cause hemodynamic instability are well established with regards to AKI-induction in dengue, the absence of shock and hypotension in a subgroup of patients with AKI in severe dengue points to the involvement of other mechanisms of injury which are discussed below.

A recent study compared the levels of cytokines in the acute phase of dengue and COVID-19, and found high levels of several cytokines throughout the course of these diseases, including high levels of immunosuppressive cytokines such as IL-10. Elevated IL-10 levels during the onset of viral infections can likely result in an inadequate antiviral immune response, which can lead to disease severity³³.

Dengue virus appears to have broad cell tropism, replicating in hepatocytes, type II pneumocytes and cardiac fibers, as well as resident and circulating monocytes/macrophages and endothelial cells³⁶. A study with histopathological analysis after death from dengue showed microabscesses in the heart, lungs, brain and kidneys³⁷.

Added to this, the presence of viral particles in the kidney tissue after the death of a patient with dengue, revealed in a study that applied the immunological technique, supports the hypothesis of possible direct kidney damage³⁸. More recently, evidence has emerged that the dengue virus, when infecting the kidney tissue, may be associated with the development of glomerulopathies, such as, for example, focal and segmental glomerulosclerosis³⁹.

Another hypothesis of kidney injury induced by dengue is immune complex-mediated glomerular damage. Glomerular deposits of IgG, IgM and C3 were found in patients with dengue-induced renal failure⁴⁰. After injecting the dengue virus in adult mice, Boonpucknavig et al. found proliferating glomerular lesions in the second week, and there were immune complexes in the third week⁴¹.

This issue is not definitively settled. For instance, Wiwanitkit commenting on studies carried out by himself and other researchers on the characteristics of the derived dengue virus-immunoglobulin immune complex considered It unlikely that immune complexes play a significative role in the pathogenesis of the AKI associated with dengue infection. Further studies in this field are therefore needed⁴²,⁴³.

On the other hand, some studies involving IL-17 may reinforce the role of the autoimmune response in severe dengue as a cause of AKI. Cytokines are needed to trigger the inflammatory response in host defense. IL-17 appears to play a significant role in immune-mediated glomerular diseases⁴⁴. Additionally, the role of IL-17 in the pathogenesis of dengue has been studied. Jain et al. associated high levels of IL-17 with severe dengue³¹. Recently, a study in mice with ischemia-induced AKI demonstrated that the neutralization of some cytokine members of the IL-17 family attenuated tubular damage, renal oxidative stress and renal inflammation⁴⁵.

Rhabdomyolysis, characterized by the extravasation of muscle content, including electrolytes, myoglobin and other muscle proteins, has also been described as a mechanism for AKI development. It is estimated that 13-50% of patients with rhabdomyolysis by any cause have AKI⁴⁶. Muscle biopsies from patients with rhabdomyolysis reveal muscle abnormalities such as inflammatory infiltrates and myonecrosis. In dengue, rhabdomyolysis is mediated by direct viral muscle invasion or by myotoxic cytokines, which can cause AKI by deposition of myoglobin along the renal tubules and its precipitation after interacting with the Tamm-Horsfall protein in the presence of acidic urine, leading to tubular obstruction. Myoglobin can also lead to tubular damage and intrarenal vasoconstriction⁴⁶,⁴⁷.

AKI by hemolytic uremic syndrome (HUS) has been described in patients with severe dengue This clinical situation is composed of hemolytic anemia, thrombocytopenia and AKI⁴⁸. Histopathological analyzes of patients with HUS revealed the presence of glomerular microthrombi, confirming renal impairment in these individuals⁴⁹.

Management of dengue-induced AKI

Dengue patients who develop AKI need longer hospital stay (an increase of, on average, 3 days) and there is higher mortality among patients with severe dengue-induced AKI²⁶. This shows that AKI plays an important role in the prognosis of patients with dengue. Although the aspects of longer hospital stay and mortality point to a worse prognosis for the patient, the specific treatment for dengue-induced AKI is still limited and not very well established.

Patient assessment in the case of warning signs of severe dengue fever together with blood volume assessment are important starting points for the prevention of AKI in dengue patients. Fluid administration should be optimized (preferably crystalloid) with infusion rates and controlled tonicities, to avoid osmolarity disorders, fluid overload and worsening of intravascular fluid extravasation⁵⁰.

The maintenance of electrolyte balance should be prioritized, due to the high prevalence of hyponatremia in these patients, and it is important that fluid therapy bear a higher tonicity, if such electrolyte abnormality is detected. Monitoring serum creatine phosphokinase (CPK) levels is important for early detection of rhabdomyolysis⁴⁸,⁵⁰. The use of steroids in patients with dengue is still controversial, and there is no indication for their use for AKI prevention in patients with dengue⁴⁸,⁵¹,⁵².

Finally, renal replacement therapy may be necessary in some patients with AKI, especially in the presence of refractory uremia and hypercatabolism, metabolic acidosis, hyperkalemia and hypervolemia. In unstable patients with dengue hemorrhagic fever and AKI undergoing dialysis treatment, continuous hemodialysis has been recommended in those services where it is available, with the suggestion that peritoneal dialysis is associated with worse outcomes³⁵,⁵⁰,⁵³.

The prompt and careful medical evaluation of patients with severe dengue is very important, with maintenance of blood volume, avoiding the use of nephrotoxic drugs, with clinical and laboratory monitoring for early identification of AKI to enable better management of the condition and avoid its complications.

We emphasize the need for post-discharge follow-up of individuals who developed AKI in dengue. It is known that patients with acute renal involvement, without previous CKD, can progress to CKD. In cases of individuals with acute-on-chronic kidney disease associated with dengue, progression to more advanced stages of the disease may occur⁵⁴,⁵⁵.

References

• ¹
  World Health Organization (WHO). Dengue bulletin. Geneva: WHO; 2020.
• ²
  World Health Organization (WHO). Dengue and severe dengue [Internet]. Geneva: WHO; 2021; [cited 2021 Jul 12]. Available from:https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
  » https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
• ³
  Aurpibul L, Khumlue P, Ayuthaya SI, Oberdorfer P. Dengue shock syndrome in an infant. BMJ Case Rep [Internet]. 2014; 2014:bcr2014205621. Available from: https://casereports.bmj.com/content/2014/bcr-2014-205621
  » https://casereports.bmj.com/content/2014/bcr-2014-205621
• ⁴
  Cattarino L, Rodriguez-Barraquer I, Imai N, Cummings DAT, Ferguson NM. Mapping global variation in dengue transmission intensity. Sci Transl Med. 2020 Jan;12(528):1-11.
• ⁵
  Ministério da Saúde (BR). Boletim epidemiológico. Monitoramento dos casos de Arboviroses urbanas transmitidas pelo Aedes (dengue, chikungunya e Zika), semanas epidemiológicas 1 a 50, 2020. Bol Epidemiológico Arboviroses. 2020;51(24):1-13.
• ⁶
  Ministério da Saúde (BR). Monitoramento dos casos de arboviroses urbanas causados por vírus transmitidos por Aedes (dengue, chikungunya e zika), semanas epidemiológicas 1 a 53, 2020. Bol Epidemiológico [Internet]. 2021; 52(3):1-31. Available from: https://www.gov.br/saude/pt-br/media/pdf/2021/fevereiro/01/boletim_epidemiologico_svs_3.pdf
  » https://www.gov.br/saude/pt-br/media/pdf/2021/fevereiro/01/boletim_epidemiologico_svs_3.pdf
• ⁷
  Ministério da Saúde (BR). Monitoramento dos casos de Arboviroses urbanas transmitidas pelo Aedes (dengue, chikungunya e Zika). Bol Epidemiológico Arboviroses. 2019;51(24):1-13.
• ⁸
  Simmons CP, Farrar JJ, Van Vinh Chau N, Wills B. Dengue [Internet]. 2012 Apr; [cited 2021 Jul 12]; 366(15):1423-32. Available from: https://www.nejm.org/doi/full/10.1056/NEJMra1110265
  » https://www.nejm.org/doi/full/10.1056/NEJMra1110265
• ⁹
  Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res. 2016;2016(3):6803098.
• ¹⁰
  Guzman MG, Harris E. Dengue. Lancet. 2015 Jan;385(9966):453-65.
• ¹¹
  Bezerra JMT, Sousa SC, Tauil PL, Carneiro M, Barbosa DS. Entry of dengue virus serotypes and their geographic distribution in Brazilian federative units: a systematic review. Rev Bras Epidemiol. 2021 Apr;24:e210020. DOI: https://doi.org/10.1590/1980-549720210020
  » https://doi.org/10.1590/1980-549720210020
• ¹²
  Mustafa MS, Rasotgi V, Jain S, Gupta V. Discovery of fifth serotype of dengue virus (denv-5): a new public health dilemma in dengue control. Med J Arm Forces [Internet]. 2015 Jan; [cited 2021 Aug 26]; 71:67-70. Available from: https://pubmed.ncbi.nlm.nih.gov/25609867/
  » https://pubmed.ncbi.nlm.nih.gov/25609867/
• ¹³
  Normile D. Tropical Medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science. 2013 Oct;342(6157):415.
• ¹⁴
  Taylor-Robinson A. A putative fifth serotype of dengue - potential implications for diagnosis, therapy and vaccine design. Int J Clin Med Microbiol [Internet]. 2016 Mar; [citado 2021 Nov 25]; 1(1). Available from: https://www.graphyonline.com/archives/IJCMM/2016/IJCMM-101/index.php
  » https://www.graphyonline.com/archives/IJCMM/2016/IJCMM-101/index.php
• ¹⁵
  Ajlan BA, Alafif MM, Alawi MM, Akbar NA, Aldigs EK, Madani TA. Assessment of the new World Health Organization’s dengue classification for predicting severity of illness and level of healthcare required. PLoS Negl Trop Dis [Internet]. 2019; [cited 2021 Jul 12]; 13(8):e0007144. Available from:https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007144
  » https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007144
• ¹⁶
  World Health Organization (WHO). Dengue guidelines for diagnosis, treatment, prevention and control. Geneva: WHO; 2009.
• ¹⁷
  Diptyanusa A, Phumratanaprapin W, Phonrat B, Poovorawan K, Hanboonkunupakarn B, Sriboonvorakul N, et al. Characteristics and associated factors of acute kidney injury among adult dengue patients: a retrospective single-center study. PLoS One. 2019;14(1):e0210360.
• ¹⁸
  Cardoso IM, Cabidelle ASA, Borges PCL, Lang CF, Calenti FG, Nogueira LO, et al. Dengue: formas clínicas e grupos de risco em município de alta incidência do sudeste do Brasil. Rev Soc Bras Med Trop. 2011 Aug;44(4):430-5.
• ¹⁹
  Kuo MC, Lu PL, Chang JM, Lin MY, Tsai JJ, Chen YH, et al. Impact of renal failure on the outcome of dengue viral infection. Clin J Am Soc Nephrol [Internet]. 2008 Sep; [cited 2021 Jul 12]; 3(5):1350-6. Available from: https://cjasn.asnjournals.org/content/3/5/1350
  » https://cjasn.asnjournals.org/content/3/5/1350
• ²⁰
  Ken FV, Eng CC, Hoo YK, Ming LJ, Yik CC, Mohammad Nor FS, et al. 060 Prevalance and outcome of acute kidney injury in dengue patients in suburban area of Pahang. Kidney Int Rep. 2017;2(4):S5. DOI: http://dx.doi.org/10.1016/j.ekir.2017.06.032
  » http://dx.doi.org/10.1016/j.ekir.2017.06.032
• ²¹
  Mehra N, Patel A, Abraham G, Reddy YNV, Reddy YNV. Acute kidney injury in dengue fever using acute kidney injury network criteria: incidence and risk factors. Trop Doct [Internet]. 2012; [cited 2021 Jul 12]; 42(3):160-2. Available from: https://pubmed.ncbi.nlm.nih.gov/22472317/
  » https://pubmed.ncbi.nlm.nih.gov/22472317/
• ²²
  Daher EDF, Silva GBJ, Vieira APF, Souza JB, Falcão FS, Costa CR, et al. Acute kidney injury in a tropical country: a cohort study of 253 patients in an infectious diseases intensive care unit. Rev Soc Bras Med Trop. 2014 Jan/Feb;47(1):86-9.
• ²³
  Diptyanusa A, Phumratanaprapin W. Predictors and outcomes of dengue-associated acute kidney injury. Am J Trop Med Hyg [Internet]. 2021; [cited 2021 Nov 25]. 105(1):24-30. Available from:https://www.ajtmh.org/view/journals/tpmd/105/1/article-p24.xml
  » https://www.ajtmh.org/view/journals/tpmd/105/1/article-p24.xml
• ²⁴
  Gurugama P, Jayarajah U, Wanigasuriya K, Wijewickrama A, Perera J, Seneviratne SL. Renal manifestations of dengue virus infections. J Clin Virol. 2018;101:1-6. DOI: http://dx.doi.org/10.1016/j.jcv.2018.01.001
  » http://dx.doi.org/10.1016/j.jcv.2018.01.001
• ²⁵
  Patel ML, Himanshu D, Chaudhary SC, Atam V, Sachan R, Misra R, et al. Clinical characteristic and risk factors of acute kidney injury among dengue viral infections in adults: a retrospective analysis. Indian J Nephrol [Internet]. 2019 Jan; [cited 2021 Jul 12]; 29(1):15-21. Available from: https://pubmed.ncbi.nlm.nih.gov/30814788/
  » https://pubmed.ncbi.nlm.nih.gov/30814788/
• ²⁶
  Mallhi TH, Khan AH, Adnan AS, Sarriff A, Khan YH, Jummaat F. Incidence, characteristics and risk factors of acute kidney injury among dengue patients: a retrospective analysis. PLoS One [Internet]. 2015 Sep; [cited 2021 Jul 12]; 10(9):e0138465. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138465
  » https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138465
• ²⁷
  Thomas ETA, George J, Sruthi D, Vineetha NS, Gracious N. Clinical course of dengue fever and its impact on renal function in renal transplant recipients and patients with chronic kidney disease. Nephrology. 2019 May;24(5):564-8.
• ²⁸
  Srikiatkhachorn A, Mathew A, Rothman AL. Immune mediated cytokine storm and its role in severe dengue. Semin Immunopathol [Internet]. 2017 Jul; [cited 2021 Jul 13]; 39(5):563. Available from: https://pubmed.ncbi.nlm.nih.gov/28401256/
  » https://pubmed.ncbi.nlm.nih.gov/28401256/
• ²⁹
  Luplerdlop N, Missé D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, et al. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep [Internet]. 2006 Nov; [cited 2021 Aug 26]; 7(11):1176-81. Available from: https://pubmed.ncbi.nlm.nih.gov/17028575/
  » https://pubmed.ncbi.nlm.nih.gov/17028575/
• ³⁰
  St John AL, Rathore APS, Raghavan B, Ng ML, Abraham SN. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife [Internet]. 2013 Apr; [cited 2021 Aug 26]; 2:e00481. Available from: https://pubmed.ncbi.nlm.nih.gov/23638300/
  » https://pubmed.ncbi.nlm.nih.gov/23638300/
• ³¹
  Jain A, Pandey N, Garg R, Kumar R. IL-17 level in patients with Dengue virus infection & its association with severity of illness. J Clin Immunol [Internet]. 2013 Apr; [cited 2021 Jul 13]; 33(3):613-8. Available from: https://pubmed.ncbi.nlm.nih.gov/23274801/
  » https://pubmed.ncbi.nlm.nih.gov/23274801/
• ³²
  Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol [Internet]. 2011 Jul; [cited 2021 Jul 13]; 11;532-43. Available from: https://pubmed.ncbi.nlm.nih.gov/21760609/
  » https://pubmed.ncbi.nlm.nih.gov/21760609/
• ³³
  Dayarathna S, Jeewandara C, Gomes L, Somathilaka G, Jayathilaka D, Vimalachandran V, et al. Similarities and differences between the ‘cytokine storms’ in acute dengue and COVID-19. Sci Rep [Internet]. 2020 Dec; [cited 2021 Jul 13]; 10(1):19839. Available from: https://pubmed.ncbi.nlm.nih.gov/33199778/
  » https://pubmed.ncbi.nlm.nih.gov/33199778/
• ³⁴
  Lima EQ, Gorayeb FS, Zanon JR, Nogueira ML, Ramalho HJ, Burdmann EA. Dengue haemorrhagic fever-induced acute kidney injury without hypotension, haemolysis or rhabdomyolysis. Nephrol Dial Transplant [Internet]. 2007 Nov; 22(11):3322-6. Available from: http://www.oxfordjournals.org/our_journals/ndtplus/
  » http://www.oxfordjournals.org/our_journals/ndtplus/
• ³⁵
  Lee IK, Liu JW, Yang KD. Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg. 2009 Apr;80(4):651-5.
• ³⁶
  Póvoa TF, Alves AMB, Oliveira CAB, Nuovo GJ, Chagas VLA, Paes MV. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One. 2014 Apr;9(4):e83386.
• ³⁷
  Ahsan J, Ahmad S, Rafi T. Postmortem findings in fatal dengue haemorrhagic fever. J Coll Physicians Surg Pak [Internet]. 2018 Jun; [cited 2021 Jul 13]; 28(6):S137-9. Available from: https://pubmed.ncbi.nlm.nih.gov/29866250/
  » https://pubmed.ncbi.nlm.nih.gov/29866250/
• ³⁸
  Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infectedhuman tissues, by immunohistochemistryand in situ hybridization. J Infect Dis. 2004 Apr;189(8):1411-8.
• ³⁹
  Araújo SA, Cordeiro TM, Belisário AR, Araújo RFA, Marinho PES, Kroon EG, et al. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection. Clin Kidney J. 2019 Jun;12(3):355-61.
• ⁴⁰
  Futrakul P, Poshyachinda V, Mitrakul C, Kun-Anake C, Boonpucknavig V, Boompucknavig S, et al. Renal involvement and reticulo-endothelial-system clearance in dengue hemorrhagic fever. J Med Assoc Thai [Internet]. 1973 Jan; [cited 2021 Jul 13]; 56(1):33-9. Available from: https://pubmed.ncbi.nlm.nih.gov/4685998/
  » https://pubmed.ncbi.nlm.nih.gov/4685998/
• ⁴¹
  Boonpucknavig S, Vuttiviroj O, Boonpucknavig V. Infection of young adult mice with dengue virus type 2. Trans R Soc Trop Med Hyg [Internet]. 1981 Jan; [cited 2021 Jul 13]; 75(5):647-53. Available from: https://academic.oup.com/trstmh/article/75/5/647/1902330
  » https://academic.oup.com/trstmh/article/75/5/647/1902330
• ⁴²
  Wiwanitkit V. Letter to the Editor: immune complex: does it have a role in pathogenesis of renal failure in dengue infection? Ren Fail. 2005 Jan;27(6):803-4. DOI: https://doi.org/10.1080/08860220500244914
  » https://doi.org/10.1080/08860220500244914
• ⁴³
  Wiwanitkit V. Dengue virus nonstructural-1 protein and its structural correlation to human integrin/adhesin proteins. Internet J Infect Dis. 2012;4(1):2-5.
• ⁴⁴
  Schmidt T, Luebbe J, Paust H, Panzer U. Mechanisms and functions of IL-17 signaling in renal autoimmune diseases. Mol Immunol [Internet]. 2018 Dec; [cited 2021 Jul 13]; 104:90-9. Available from: https://pubmed.ncbi.nlm.nih.gov/30448610/
  » https://pubmed.ncbi.nlm.nih.gov/30448610/
• ⁴⁵
  Wang F, Yin J, Lin Y, Zhang F, Liu X, Zhang G, et al. IL-17C has a pathogenic role in kidney ischemia/reperfusion injury. Kidney Int [Internet]. 2020 Jun; [cited 2021 Jul 13]; 97(6):1219-29. Available from: https://pubmed.ncbi.nlm.nih.gov/32331702/
  » https://pubmed.ncbi.nlm.nih.gov/32331702/
• ⁴⁶
  Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72.
• ⁴⁷
  Mishra A, Kumar Singh V, Nanda S. Rhabdomyolysis and acute kidney injury in dengue fever. BMJ Case Sep [Internet]. 2015; 2015:bcr2014209074. Available from: https://pubmed.ncbi.nlm.nih.gov/26174727/
  » https://pubmed.ncbi.nlm.nih.gov/26174727/
• ⁴⁸
  Oliveira JFP, Burdmann EA. Dengue-associated acute kidney injury. Clin Kidney J. 2015 Dec;8(6):681-5.
• ⁴⁹
  Wiersinga WJ, Scheepstra CG, Kasanardjo JS, Vries PJ, Zaaijer H, Geerlings SE. Dengue fever-inducedhemolytic uremic syndrom. Clin Infect Dis. 2006;43:800-1.
• ⁵⁰
  Vachvanichsanong P, Thisyakorn U, Thisyakorn C. Dengue hemorrhagic fever and the kidney. Arch Virol. 2016 Apr;161(4):771-8.
• ⁵¹
  Nguyen THT, Nguyen THQ, Vu TT, Farrar J, Hoang TL, Dong THT, et al. Corticosteroids for dengue - why don’t they work? PLoS Negl Trop Dis [Internet]. 2013 Dec; [cited 2021 Jul 13]; 7(12):e2592. Available from: https://pubmed.ncbi.nlm.nih.gov/24349598/
  » https://pubmed.ncbi.nlm.nih.gov/24349598/
• ⁵²
  Tam DTH, Ngoc TV, Tien NTH, Kieu NTT, Thuy TTT, Thanh LTC, et al. Effects of short-course oral corticosteroid therapy in early dengue infection in vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis [Internet]. 2012 Nov; [cited 2021 Jul 13]; 55(9):1216-24. Available from: https://pubmed.ncbi.nlm.nih.gov/22865871/
  » https://pubmed.ncbi.nlm.nih.gov/22865871/
• ⁵³
  Goonasekera CDA, Thenuwara BG, Kumarasiri RPV. Peritoneal dialysis in dengue shock syndrome may be detrimental. J Trop Med. 2012;2012:917947.
• ⁵⁴
  Yu SMW, Bonventre JV. Acute kidney injury and maladaptive tubular repair leading to renal fibrosis. Curr Opin Nephrol Hypertens [Internet]. 2020 May; [cited 2021 Jul 13]; 29(3):310-8. Available from: https://pubmed.ncbi.nlm.nih.gov/32205583/
  » https://pubmed.ncbi.nlm.nih.gov/32205583/
• ⁵⁵
  Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med [Internet]. 2014 Jul; [cited 2021 Jul 13]; 371(1):58-66. Available from: https://pubmed.ncbi.nlm.nih.gov/24988558/
  » https://pubmed.ncbi.nlm.nih.gov/24988558/

Publication Dates

• Publication in this collection
  23 Feb 2022
• Date of issue
  Apr-Jun 2022

History

• Received
  12 Sept 2021
• Accepted
  01 Dec 2021